An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
Hanna Jankevics Jones
Advertisement
Hanna Jankevics Jones, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.
Articles by Hanna Jankevics Jones
Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
Advertisement
Latest Updated Articles
Shining a Light on Lipid Nanoparticle CharacterizationPublished: September 15th 2022 | Updated:
- Taking a Closer Look at Lipid Nanoparticle Characterization
Published: November 8th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
